News|Articles|June 15, 2021
Process Development Improvements Post-Pandemic
Author(s)Pharmaceutical Technology Editors
What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?
Advertisement
In this expert interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, explains key actions the biopharma can learn from its response to the COVID-19 pandemic that can be applied to improve process development for non-pandemic development programs.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
2
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
3
PharmTech Weekly Roundup—August 14, 2026
4
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
5